Free Trial Information
BioCentury | Apr 15, 2013
Company News

Heartland BioTechnologies LLC, Molecular Geriatrics deal

...throughput screens for G-protein coupled receptors and may be used in the company's collaboration with Gene Logic...
Read More
BioCentury | Nov 19, 2012
Company News

DioGenix, National Multiple Sclerosis Society deal

...repurpose FDA-approved drugs as new MS treatments. In 2008, life science fund Nerveda LLC paid Ore Pharmaceuticals...
Read More
BioCentury | Nov 7, 2011
Company News

Sialix management update

...Diagnostic Hired: Norrie Russell as president and CEO, formerly president of Ocimum Biosolutions Ltd. 's Gene Logic...
Read More
BioCentury | Nov 1, 2010
Financial News

Ore Pharmaceuticals completes private placement of notes

Ore Pharmaceuticals Holdings Inc. (Pink:ORXE), Cambridge, Mass. Business: Autoimmune, Genomics Date completed: 10/22/10 Type: Private placement of notes Raised: $4.2 million Investor: Steel Partners Note: The note matures in five years. WIR Staff autoimmune...
Read More
BioCentury | Nov 1, 2010
Financial News

Ore Pharmaceuticals completes private placement

Ore Pharmaceuticals Holdings Inc. (Pink:ORXE), Cambridge, Mass. Business: Autoimmune, Genomics Date completed: 10/22/10 Type: Private placement Raised: $1.1 million Shares: 3.1 million Price: $0.35 Shares after offering: 8.6 million Investor: Steel Partners WIR Staff autoimmune...
Read More
BioCentury | Oct 4, 2010
Financial News

Ore Pharmaceuticals financial update

...with the SEC. The company said it intends to maintain listing on the Pink Sheets. Ore Pharmaceuticals...
Read More
BioCentury | Sep 13, 2010
Company News

Ocimum management update

...Ltd. , Hyderabad, India Business: Supply/Service, Bioinformatics, Microarrays Hired: Norrie Russell as president of Ocimum's Gene Logic...
Read More
BioCentury | Apr 12, 2010
Financial News

Ore Pharmaceuticals financial update

...Ore Pharmaceutical was de-listed from NASDAQ for failure to comply with the exchange's listing requirements. Ore Pharmaceuticals...
Read More
BioCentury | Sep 28, 2009
Financial News

Ore Pharmaceuticals financial update

...bid price requirement for continued listing. The company has until March 15 to regain compliance. Ore Pharmaceuticals...
Read More
BioCentury | Aug 24, 2009
Company News

Ore Pharmaceuticals, Lundbeck deal

...Ore (formerly Gene Logic Inc. ) disclosed in its 2Q09 earnings that it exercised its option to...
...2007 reprofiling deal with Lundbeck. Further terms were not disclosed (see BioCentury, July 2, 2007). Ore Pharmaceuticals...
Read More
Items per page:
1 - 10 of 303
BioCentury | Apr 15, 2013
Company News

Heartland BioTechnologies LLC, Molecular Geriatrics deal

...throughput screens for G-protein coupled receptors and may be used in the company's collaboration with Gene Logic...
Read More
BioCentury | Nov 19, 2012
Company News

DioGenix, National Multiple Sclerosis Society deal

...repurpose FDA-approved drugs as new MS treatments. In 2008, life science fund Nerveda LLC paid Ore Pharmaceuticals...
Read More
BioCentury | Nov 7, 2011
Company News

Sialix management update

...Diagnostic Hired: Norrie Russell as president and CEO, formerly president of Ocimum Biosolutions Ltd. 's Gene Logic...
Read More
BioCentury | Nov 1, 2010
Financial News

Ore Pharmaceuticals completes private placement of notes

Ore Pharmaceuticals Holdings Inc. (Pink:ORXE), Cambridge, Mass. Business: Autoimmune, Genomics Date completed: 10/22/10 Type: Private placement of notes Raised: $4.2 million Investor: Steel Partners Note: The note matures in five years. WIR Staff autoimmune...
Read More
BioCentury | Nov 1, 2010
Financial News

Ore Pharmaceuticals completes private placement

Ore Pharmaceuticals Holdings Inc. (Pink:ORXE), Cambridge, Mass. Business: Autoimmune, Genomics Date completed: 10/22/10 Type: Private placement Raised: $1.1 million Shares: 3.1 million Price: $0.35 Shares after offering: 8.6 million Investor: Steel Partners WIR Staff autoimmune...
Read More
BioCentury | Oct 4, 2010
Financial News

Ore Pharmaceuticals financial update

...with the SEC. The company said it intends to maintain listing on the Pink Sheets. Ore Pharmaceuticals...
Read More
BioCentury | Sep 13, 2010
Company News

Ocimum management update

...Ltd. , Hyderabad, India Business: Supply/Service, Bioinformatics, Microarrays Hired: Norrie Russell as president of Ocimum's Gene Logic...
Read More
BioCentury | Apr 12, 2010
Financial News

Ore Pharmaceuticals financial update

...Ore Pharmaceutical was de-listed from NASDAQ for failure to comply with the exchange's listing requirements. Ore Pharmaceuticals...
Read More
BioCentury | Sep 28, 2009
Financial News

Ore Pharmaceuticals financial update

...bid price requirement for continued listing. The company has until March 15 to regain compliance. Ore Pharmaceuticals...
Read More
BioCentury | Aug 24, 2009
Company News

Ore Pharmaceuticals, Lundbeck deal

...Ore (formerly Gene Logic Inc. ) disclosed in its 2Q09 earnings that it exercised its option to...
...2007 reprofiling deal with Lundbeck. Further terms were not disclosed (see BioCentury, July 2, 2007). Ore Pharmaceuticals...
Read More
Items per page:
1 - 10 of 303